BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16877036)

  • 1. Determinations of the inclusion complex between gossypol and beta-cyclodextrin.
    Shen YL; Ying W; Yang SH; Wu LM
    Spectrochim Acta A Mol Biomol Spectrosc; 2006 Sep; 65(1):169-72. PubMed ID: 16877036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on structure and characterization of inclusion complex of gossypol/beta cyclodextrin.
    Shen YL; Yang SH; Wu LM; Ma XY
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Apr; 61(6):1025-8. PubMed ID: 15741097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.
    Villaverde J; Morillo E; Pérez-Martínez JI; Ginés JM; Maqueda C
    J Agric Food Chem; 2004 Feb; 52(4):864-9. PubMed ID: 14969543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectroscopic study and antioxidant properties of the inclusion complexes of rosmarinic acid with natural and derivative cyclodextrins.
    Celik SE; Ozyürek M; Tufan AN; Güçlü K; Apak R
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 May; 78(5):1615-24. PubMed ID: 21377406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion complex of trimethoprim with beta-cyclodextrin.
    Li N; Zhang YH; Wu YN; Xiong XL; Zhang YH
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):824-9. PubMed ID: 16011886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of aqueous and solid inclusion complexes of diuron and isoproturon with beta-cyclodextrin.
    Dupuy N; Marquis S; Vanhove G; Bria M; Kister J; Vrielynck L
    Appl Spectrosc; 2004 Jun; 58(6):711-8. PubMed ID: 15198824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterisation of the supramolecular structure of luteolin/cyclodextrin inclusion complex.
    Liu B; Li W; Zhao J; Liu Y; Zhu X; Liang G
    Food Chem; 2013 Nov; 141(2):900-6. PubMed ID: 23790865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL; Pore YV; Kuchekar BS; Late SG
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion complexes of pyrimethamine in 2-hydroxypropyl-beta-cyclodextrin: characterization, phase solubility and molecular modelling.
    de Araújo MV; Vieira EK; Lázaro GS; de Souza Conegero L; Ferreira OP; Almeida LS; Barreto LS; da Costa NB; Gimenez IF
    Bioorg Med Chem; 2007 Sep; 15(17):5752-9. PubMed ID: 17583516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of inclusion complex of epothilone A with cyclodextrins.
    Xiao CF; Li K; Huang R; He GJ; Zhang JQ; Zhu L; Yang QY; Jiang KM; Jin Y; Lin J
    Carbohydr Polym; 2014 Feb; 102():297-305. PubMed ID: 24507285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.
    de Araujo DR; Tsuneda SS; Cereda CM; Del G F Carvalho F; Preté PS; Fernandes SA; Yokaichiya F; Franco MK; Mazzaro I; Fraceto LF; de F A Braga A; de Paula E
    Eur J Pharm Sci; 2008 Jan; 33(1):60-71. PubMed ID: 18036789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the inclusion compound of rutin with beta-cyclodextrin].
    Shao W; Wang D; Mi G; Wang C
    Zhong Yao Cai; 1998 Jan; 21(1):31-3. PubMed ID: 12567968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the characterization of beta-cyclodextrin-acetylferrocene-thiosemicarbazone inclusion complex and micro-environmental effects].
    Zhang J; Liu WY; Zhang X
    Guang Pu Xue Yu Guang Pu Fen Xi; 2005 Oct; 25(10):1568-72. PubMed ID: 16395884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
    Aleem O; Kuchekar B; Pore Y; Late S
    J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectroscopic investigations and crystal structure from synchrotron powder data of the inclusion complex of beta-cyclodextrin with atenolol.
    Borodi G; Bratu I; Dragan F; Peschar R; Helmholdt RB; Hernanz A
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Oct; 70(5):1041-8. PubMed ID: 18061532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of constant for the inclusion complex of Yinqiao volatile oil with beta-cyclodextrin].
    Ma KF; Ren Y; Wang X; Mao L
    Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):739-42. PubMed ID: 15506281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.